Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

Allergies – Always a story

Saycomms looks into the seasonal trend of allergies stories in the media and the communication campaigns launched in UK in 2015.

Say Communications

When is sun safety doing more harm than good?

Say Communications analyses the impact of sun safety campaigns in the news and on consumers

Say Communications

Energy drinks and heart disease

Say Communications analyses the link between energy drinks and heart disease and how the issue has been covered in the media.

Say Communications

23andMe – is DNA screening ethical?

Say Communications reflects on the ethical side of DNA screening.

Say Communications

- PMLiVE

Amgen starts shipping Corlaner in US

Firm also reports healthy financial growth in the first quarter

- PMLiVE

Teva offers $40bn for Mylan as Perrigo backs away

Generic drug industry could be shaken up if deals go through

- PMLiVE

Astellas signs up to immuno-oncology deal

Japanese firm the latest pharma company to buy into the next-gen cancer therapy area

- PMLiVE

Creston acquires How Splendid

Agency looks to bolster its digital offering with new buy

- PMLiVE

Reaching beyond adherence

To truly achieve patient engagement you also need to engage those influencing them

Teva Pharma logo

Teva slapped with $512m fine on pay-for-delay deal

Israeli firm pays out to settle claims it hindered use of generic Provigil

Making a difference with mobile health

Sanofi talks to PME about its latest mHealth initiative and tackling the diabetes epidemic

Daiichi Sankyo logo

Daiichi Sankyo offloads stake in India’s Sun Pharma

Japanese firm wants to shed its share of the generic Indian drugmaker

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links